Olathe, KS, April 1, 2020 – Ronawk, LLC announced today that they are making their T-Block cell culture technology available to researchers and commercial entities working to combat the COVID-19 pandemic.
Ronawk’s platform technology, Tissue Blocks (T-Blocks), are 3D substrates that are both modular and expandable. With T-Blocks, human cells can be rapidly expanded to generate up to one trillion cells to use for research and development of therapeutic, diagnostic, or antibody production applications. T-Blocks have primarily been demonstrated for use with adult stem cells, but can also be used with other cells types to dramatically increase cell and biologics production to combat the COVID-19 pandemic.
As a scientific expert, I would like to add, what AJ is promoting is 💯 accurate. They are great people, honest company that could help accelerate COVID-19 research!Chad Highfill, Ph.D.
Calling all scientists and other brilliant people! Let your creativity not bind you as you think of new ways to manage SARS-CoV-2 with T-Blocks and Ronawk at your side!Michele Pritchard, Ph.D.
To learn more, please contact us at [email protected], to determine if we can collaborate to support your efforts in COVID-19 research.